|
TBC1D8B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.646700E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.999330E-03 |
| Normal-vs-Stage2 |
8.122600E-03 |
| Normal-vs-Stage3 |
7.475400E-01 |
| Normal-vs-Stage4 |
1.249410E-04 |
| Stage1-vs-Stage2 |
7.383800E-01 |
| Stage1-vs-Stage3 |
2.777400E-01 |
| Stage1-vs-Stage4 |
4.350500E-02 |
| Stage2-vs-Stage3 |
2.366800E-01 |
| Stage2-vs-Stage4 |
2.361800E-01 |
| Stage3-vs-Stage4 |
3.678400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.517900E-03 |
| Normal-vs-AfricanAmerican |
2.110500E-02 |
| Normal-vs-Asian |
4.261300E-03 |
| Caucasian-vs-AfricanAmerican |
9.598200E-01 |
| Caucasian-vs-Asian |
4.215800E-01 |
| AfricanAmerican-vs-Asian |
4.281400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.5533000000072E-05 |
| Normal-vs-Female |
4.406200E-01 |
| Male-vs-Female |
5.862800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.440370E-03 |
| Normal-vs-Extreme_Weight |
9.93290000028679E-07 |
| Normal-vs-Obese |
2.463600E-01 |
| Normal-vs-Extreme_Obese |
9.124700E-03 |
| Normal_Weight-vs-Extreme_Weight |
7.160800E-01 |
| Normal_Weight-vs-Obese |
9.520400E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.174200E-01 |
| Extreme_Weight-vs-Obese |
1.258250E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.846200E-01 |
| Obese-vs-Extreme_Obese |
1.617800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.903400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.456300E-02 |
| Normal-vs-Age(61-80Yrs) |
2.396900E-04 |
| Normal-vs-Age(81-100Yrs) |
1.438150E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.201800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.712420E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.532400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.256600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.520400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.521980E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.59370000002635E-06 |
| Normal-VS-Type2 PRCC |
4.839700E-02 |
| Normal-VS-KIRP CIMP |
7.324400E-01 |
| Normal-VS-Unclassified PRCC |
5.098000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.486200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.319600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.101400E-03 |
| Type2 PRCC-VS-KIRP CIMP |
5.552000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.257500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.588400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.263220E-01 |
| Normal-vs-N1 |
4.944400E-01 |
| Normal-vs-N2 |
1.103620E-01 |
| N0-vs-N1 |
6.947600E-01 |
| N0-vs-N2 |
8.329200E-01 |
| N1-vs-N2 |
6.889200E-01 |
|
|
